Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

557
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Drug utilization in the Maastricht Study: A comparison with nationwide data.

Medicine·2020
Same author

Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.

Diabetes technology & therapeutics·2019
Same author

Corrigendum to: Cohort Profile: The Hoorn Studies.

International journal of epidemiology·2019
Same author

Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.

BMJ open diabetes research & care·2019
Same author

High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.

Journal of clinical lipidology·2019
Same author

Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study.

Hypertension (Dallas, Tex. : 1979)·2019

相关实验视频

Updated: May 1, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.3K

在霍恩研究中代谢综合征和10年心血管疾病风险.

Jacqueline M Dekker1, Cynthia Girman, Thomas Rhodes

  • 1The Institute for Research in Extramural Medicine, VU University Medical Center, Amsterdam, The Netherlands. jm.dekker@vumc.nl

Circulation
|August 3, 2005
PubMed
概括

代谢综合征,无论定义如何,大约使欧洲人的心血管疾病风险增加了一倍. 计算个体风险因素提供了比单独使用综合征定义更清晰的临床评估.

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.7K

相关实验视频

Last Updated: May 1, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.3K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.7K

科学领域:

  • 内分泌学 在内分泌学.
  • 心血管医学 心血管医学
  • 流行病学 流行病学

背景情况:

  • 代谢综合征存在多种定义,但它们对评估心血管疾病 (CVD) 风险的临床实用性仍然不确定.
  • 这项研究比较了四个主要的代谢综合征定义:NCEP,WHO,EGIR和ACE.

研究的目的:

  • 用不同的定义来比较代谢综合征的患病率.
  • 评估这些定义与致命和非致命心血管疾病的10年风险之间的关联.

主要方法:

  • 基于人口的队列研究 (霍恩研究),对1364名年龄在50-75岁之间,没有糖尿病或之前的心血管疾病的人进行了研究.
  • 使用NCEP,WHO,EGIR和ACE定义来评估流行率和10年心血管疾病风险.

主要成果:

  • 代谢综合征的患病率在17%至32%之间.
  • 根据NCEP的定义,致命性心血管疾病 (男性) 和非致命性心血管疾病 (女性) 的风险增加了约2倍.
  • 包括胰岛素水平在内的定义与风险没有更强烈的关联,尽管具有多种风险因素的胰岛素水平更高.

结论:

  • 根据任何定义,代谢综合征与欧洲人口心血管事件风险增加约2倍有关.
  • 评估个体风险因素在临床实践中提供了比单独的综合征定义更有信息的CVD风险分层.